[Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study].
Chauvet-Gélinier
J-C
JC
Service de psychiatrie et d'addictologie, hôpital Général, CHU de Dijon, 3, rue du Faubourg-Raines, 21000 Dijon, France. jean-christophe.chauvet-gelinier@chu-dijon.fr
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D015283:Citalopram / Q000009:adverse effects / Q000627:therapeutic use*; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D017374:Paroxetine / Q000009:adverse effects / Q000627:therapeutic use*; D010555:Personality Inventory / Q000706:statistics & numerical data; D011594:Psychometrics
D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D017374:Paroxetine
Efficacité de l'escitalopram vs paroxétine sur les formes de dépressions sévères avec symptômes anxieux associés. Données issues de l'étude "Boulenger": escitalopram versus paroxétine.